- Dec 28, 2022
Twin study confirms childhood leukaemia starts in the womb
By studying rare cases of identical twins with leukaemia, scientists have shed new light on the origins of the most common type of childhood cancer – confirming it originates in the womb but that events after birth determine whether or not clinical leukaemia develops. Read more: https://www.icr.ac.uk/news-archive/twin-study-confirms-childhood-leukaemia-starts-in-the-womb-and-could-help-guide-screening-when-only-one-twin-is-affected
- Dec 23, 2022
Could CAR-T-cell therapy offer hope to children with cancer?
The immunotherapy is beginning to show promise in solid tumours, but researchers want more dedicated research in young people. Read more: https://www.nature.com/articles/d41586-022-04344-6
- Dec 22, 2022
Blastic Plasmacytoid Dendritic Cell Neoplasm in Children, Adolescents, and Young Adults
Whether occurring in the adult or pediatric population, the diagnosis of blastic plasmacytoid dendritic cell neoplasm is challenging to make and carries a poor prognosis. Read more: https://www.dermatologytimes.com/view/blastic-plasmacytoid-dendritic-cell-neoplasm-in-children-adolescents-and-young-adults
- Dec 21, 2022
Researchers have identified the origins of serious illness in children
The origins of the serious cancer-like disease LCH have been identified by researchers from Karolinska Institutet in collaboration with Karolinska University Hospital. The findings presented in Science Immunology may lead to new, targeted treatments. Read more: https://www.eurekalert.org/news-releases/974573
- Dec 20, 2022
New study achieves 99 percent remission in children who relapse with most common childhood cancer
A recent collaboration with colleagues in Shanghai Children’s Medical Center has found a new immunotherapy combination that resulted in remission for virtually all children – 99 percent – who had relapsed B-cell acute lymphoblastic leukemia (ALL). Read more: https://www.stjude.org/inspire/news/new-study-achieves-99-percent-remission-in-children-who-relapse-with-most-common-childhood-cancer.html
- Dec 19, 2022
Challenges Faced by Adolescent and Young Adult Patients With Cancer
Adolescents and young adults who have cancer also have a negative body image, financial toxicity, and concerns about family planning. Read more: https://www.oncnursingnews.com/view/challenges-faced-by-adolescent-and-young-adult-patients-with-cancer
- Dec 14, 2022
Research opens a window into understanding deadly brain tumors
Formerly known as diffuse intrinsic pontine gliomas, diffuse midline gliomas (DMGs) are highly aggressive tumors found in the midline of the brain. Their prognosis is very poor, in part because they don’t respond well to treatments such as chemotherapy and radiation. Now, research by Mariella Filbin, MD, PhD, and others in the Brain Tumor Center at the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center has uncovered new details about how these rare tumors dev
- Dec 13, 2022
Revolutionary gene therapy offers hope for untreatable cancers
Scientists in the UK have used a revolutionary new type of gene therapy to treat a young patient with relapsed T-cell leukaemia. The administration of the technique – a world first – has raised hopes it could soon help to tackle other childhood cancers and serious diseases. Read more: https://www.theguardian.com/science/2022/dec/11/revolutionary-gene-therapy-offers-hope-untreatable-cancers
- Dec 7, 2022
Study Identifies Novel Epigenetic Changes in Pediatric Brain Cancer
Investigators have identified previously unknown sets of epigenetic changes in pediatric brain tumors, which could serve as novel therapeutic targets and provide alternative treatment options for patients, according to a Northwestern Medicine study published in Nature Communications. Read more: https://news.feinberg.northwestern.edu/2022/12/05/study-identifies-novel-epigenetic-changes-in-pediatric-brain-cancer/
- Dec 6, 2022
'No child would ever contract cancer': Alberta researchers developing cancer vaccine
A research by the University of Calgary (UCalgary) is using “cutting-edge” methods to develop a highly efficient vaccine to treat the most difficult types of cancer in children. Read more: https://calgary.citynews.ca/2022/12/03/ucalgary-cancer-vaccine/